Temozolomide Capsule
Product Images NDC 72162-2663

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 72162-2663). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622663)

Label (Lbl721622663)
This is a package insert for Temozolomide Capsules containing 180 mg per capsule for oral administration. The drug is a cytotoxic medication manufactured in Turkey. The dosage instructions and storage conditions between 15°C to 30°C are provided. It is important to keep the drug out of reach of children. The NDC number for this product is 72162-2663-2. The manufacturer is Bryant Ranch Prepack, Inc., and the pharmaceutical company is Deva Holding A.S.*
FDA Label Image

Kaplan-meier Curves (Temo Fig2)

Kaplan-meier Curves (Temo Fig2)
This text provides data related to the overall survival of the ITT population in a study. The hazard ratio (HR) with a 95% confidence interval (C.I.) is reported as 0.63 (0.52 to 0.75), indicating a significant impact. The log-rank P-value is less than 0.0001, further supporting the statistical significance. The timeline is shown in months, ranging from 12 to 28, indicating the period from randomization.*
FDA Label Image

Chemical-structure (Temo Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.